Concepedia

Shaoyi Li

SL

Statistics

Publications

13

Citations

1.7K

H-Index

13

Active since

2011

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of California, San Francisco

Institut Català d'Oncologia

The University of Texas MD Anderson Cancer Center

Sarah Cannon

Shaoyi Li is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and oncology.

Publications per year

2011–2023

13

Publications

13

Novel mutations target distinct subgroups of medulloblastoma

Giles Robinson, Matthew Parker, Tanya A. Kranenburg et al. · Nature · 2012 · 853 citations · Full text

Medicine, Genetics, Oncology +17

Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer

Joachim von Pawel, Robert M. Jotte, David R. Spigel et al. · Journal of Clinical Oncology · 2014 · 344 citations · Full text

Medicine, Oncology, Pharmacology +13

<p>First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy</p>

Pamela N. Münster, Monica Mita, Amit Mahipal et al. · Cancer Management and Research · 2019 · 85 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Suzanne Trudel, Rakesh Popat et al. · New England Journal of Medicine · 2023 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

CDYL suppresses epileptogenesis in mice through repression of axonal Nav1.6 sodium channel expression

Yongqing Liu, Shirong Lai, Weining Ma et al. · Nature Communications · 2017 · 68 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

1–5 of 13